Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats

European Neuropsychopharmacology

Volumn 14, Issue 5, 2004, Pages 385-392

  Fell, M J ^a   Neill, J C ^a   Marshall, K M ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Antipsychotics; Haloperidol; Risperidone; Sexual dysfunction; Side effects; Weight gain

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESTRUS CYCLE; FEMALE; FLUID INTAKE; FOOD INTAKE; NONHUMAN; PRIORITY JOURNAL; RAT; REPRODUCTIVE TOXICITY; UTERUS WEIGHT; WEIGHT GAIN;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ESTROUS CYCLE; FEMALE; HALOPERIDOL; ORGAN SIZE; RATS; RISPERIDONE; TIME FACTORS; UTERUS; WEIGHT GAIN;

EID: 4344672426     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2003.12.001     Document Type: Article

References (40)

1. Allison D.B., Mentore J., Heo M., Chandler L.P., Cappelleri J.C., Infante M.C., Weiden P.J. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry. 156:1999;1686-1696
2. Amdisen A. Drug produced obesity: experiences with chlorpromazine, perphenazine, and clopenthixol. Dan. Med. Bull. 11:1964;182-189
3. Baptista T., Parada M., Hernandez L. Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved? Pharmacol. Biochem. Behav. 27:1987;399-405
4. Baptista T., Alvarez L., Lacruz A., de Mendoza S., Hernandez L. Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry. 23:1999;277-287
5. Baptista T., Araujo de Baptista E., Ying K., Beaulieu N.M.S., Walker D., Joober R., Lalonde J., Richard D. Comparative effects of the antipsychotics sulpiride or risperidone in rats: I. Body weight, food intake, body composition, hormones and glucose tolerance. Brain Res. 957:2002;144-151
6. Bechelli L.P.C., Lecco M.C., Acioli A., Pontes M.C. A double-blind trial of haloperidol decanoate and pipothiapazine palmitate in the maintenance treatment of schizophrenia in a public out-patient clinic. Curr. Ther. Res. 37:1985;662-671
7. Canuso C.M., Goldstein J.M., Wojcik J., Dawson R., Brandman D., Klibanski A., Schildkraut J.J., Green A.I. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res. 111:2002;11-20
8. Cutler A.J. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology. 28(Suppl. 1):2003;69-82
9. Dickson R.A., Glazer W.M. Neuroleptic-induced hyperprolactinemia. Schizophr. Res. 35:1999;S75-S86. (Suppl)
10. Favy D.A., Rio P., Maurizis J.C., Hizel C., Bignon Y.J., Bernard-Gallon D.J. Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines. Biochem. Biophys. Res. Commun. 258:1999;284-291
11. Fell, M.J., Marshall, K.M., Williams, J., Neill, J.C., in press. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats. J. Psychopharmacol.
12. Fox R.R., Laird C.W. Sexual cycles. Hafez E.S.E. Reproduction and Breeding Techniques for Laboratory Animals. 1970;107-122 Lea & Febiger, Philadelphia
13. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol. Rev. 80(4):2000;1523-1631
14. Gerardo-Gettens T., Moore B.J., Stern J.S., Horwitz B.A. Prolactin stimulates food intake in a dose-dependent manner. Am. J. Physiol. 256:1989;R276-R280
15. Gill S., Peston D., Vonderhaar B.K., Shousha S. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an immunohistological study. J. Clin. Pathol. 54:2001;956-960
16. Green A., Patel J., Goisman R., Allison D., Blackburn G. Weight gain from novel antipsychotic drugs: need for action. Gen. Hosp. Psychiatry. 22:2000;224-235
17. Hafner H. Prevention and early intervention in schizophrenia: facts and visions. Seishin Shinkeigaku Zasshi. 104:2002;1033-1054
18. Hervey E., Hervey G.R. Energy storage in female rats treated with progesterone in the absence of increased intake of food. J. Physiol. 200(2):1969;118P-119P
19. Kapur S., VanderSpek S.C., Brownlee B.A., Nobrega J.N. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J. Pharmacol. Exp. Ther. 305:2003;625-631
20. Kaur G., Kulkarni S.K. Studies on modulation of feeding behavior by atypical antipsychotics in female mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 26:2002;277-285
21. Kerr M.B., Marshall K., Senior J. The role of thromboxane in the uterotrophic response in the gravid normotensive and spontaneously hypertensive rat. J. Endocrinol. 135:1992;257-261
22. Kerr M.B., Marshall K., Senior J. A comparison of the uterotrophic response in cyclic and ovariectomized normotensive and spontaneously hypertensive rats. J. Endocrinol. 135:1992;263-269
23. Kleinberg D.L., Davis J.M., de Coster R., Van Baelen B., Brecher M. Prolactin levels and adverse events in patients treated with risperidone. J. Clin. Psychopharmacol. 19:1999;57-61
24. Kraus T., Haack M., Schuld A., Hinze-Selch D., Kuhn M., Uhr M., Pollmacher T. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am. J. Psychiatry. 156(2):1999;312-314
25. Kroeze W.K., Hufeisen S.J., Popadak B.A., Renock S.M., Steinberg S., Ernsberger P., Jayathilake K., Meltzer H.Y., Roth B.L. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2:2003;519-526
26. Kulkarni J., Riedel A., de Castella A.R., Fitzgerald P.B., Rolfe T.J., Taffe J., Burger H. Estrogen - a potential treatment for schizophrenia. Schizophr. Res. 48:2001;137-144
27. Lee M.D., Clifton P.G. Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol. Pharmacol. Biochem. Behav. 71:2002;147-154
28. Leondires M., Dong Hu Z., Tsai-Mosris J., Dufau C. Estradiol stimulates expression of two human prolactin receptor isoforms with alternate exons-1 in T47D breast cancer cells. J. Steroid Biochem. Mol. Biol. 1754:2002;1-6
29. Marshall K., Senior J. The effect of mepyramine and ranitidine on the oestrogen and anti-oestrogen stimulated rat uterus. Br. J. Pharmacol. 89:1986;251-256
30. Marshall K., Senior J. Ornithine decarboxylase inhibition and the uterotrophic response to oestrogen in rats. J. Reprod. Fertil. 76:1986;597-601
31. Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr. Bull. 25:1999;233-255
32. National Institute for Clinical Excellence, Technology Appraisal Guidance no. 43, June 2002, Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia.
33. Phaily S., Senior J. Modification of oestrogen-induced uterine hyperaemia by drugs in ovariectomised rats. J. Reprod. Fertil. 53:1978;91-97
34. Peuskens J. Prolactine elevation and sexual dysfunction. Peuskens J. A Literature Review of Prolactin in Schizophrenia, Clear Prospectives:Management Issues in Schizophrenia. vol. 1 (3):1997;17-27
35. Reynolds G.P., Zhang Z.J., Zhang X.B. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet. 359:2002;2086-2087
36. Stanton J.M. Weight gain associated with neuroleptic medication: a review. Schizophr. Bull. 21:1995;463-472
37. Schotte A., Janssen P.F., Gommeren W., Luyten W.H., Van Gompel P., Lesage A.S., De Loore K., Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. 124:1996;57-73
38. Wade G.N., Gray J.M. Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol. Behav. 22:1979;583-593
39. Wade G.N., Heller H.W. Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats. Am. J. Physiol. 264:1993;R1219-R1223
40. Wade G.N., Schneider J.E. Metabolic fuels and reproduction in female mammals. Neurosci. Biobehav. Rev. 16:1992;235-272